Patellofemoral problems after anterior cruciate ligament reconstruction RA Sachs, DM Daniel, ML Stone, RF Garfein The American journal of sports medicine 17 (6), 760-765, 1989 | 967 | 1989 |
Viral infections in short-term injection drug users: the prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphotropic viruses. RS Garfein, D Vlahov, N Galai, MC Doherty, KE Nelson American journal of public health 86 (5), 655-661, 1996 | 961 | 1996 |
Effect of a cash transfer programme for schooling on prevalence of HIV and herpes simplex type 2 in Malawi: a cluster randomised trial SJ Baird, RS Garfein, CT McIntosh, B Özler The Lancet 379 (9823), 1320-1329, 2012 | 788 | 2012 |
Risk of hepatitis C virus infection among young adult injection drug users who share injection equipment LE Thorpe, LJ Ouellet, R Hershow, SL Bailey, IT Williams, J Williamson, ... American journal of epidemiology 155 (7), 645-653, 2002 | 587 | 2002 |
Correlates of hepatitis C virus infections among injection drug users DL Thomas, D Vlahov, L Solomon, S Cohn, E Taylor, R Garfein, ... Medicine 74 (4), 212-220, 1995 | 487 | 1995 |
Prevalence and incidence of hepatitis C virus infection among young adult injection drug users RS Garfein, MC Doherty, ER Monterroso, DL Thomas, KE Nelson, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 18, S11-S19, 1998 | 441 | 1998 |
Wastewater sequencing reveals early cryptic SARS-CoV-2 variant transmission S Karthikeyan, JI Levy, P De Hoff, G Humphrey, A Birmingham, K Jepsen, ... Nature 609 (7925), 101-108, 2022 | 364 | 2022 |
Evaluation of genetic mutations associated with Mycobacterium tuberculosis resistance to amikacin, kanamycin and capreomycin: a systematic review SB Georghiou, M Magana, RS Garfein, DG Catanzaro, A Catanzaro, ... PloS one 7 (3), e33275, 2012 | 334 | 2012 |
Tuberculosis and illicit drug use: review and update RG Deiss, TC Rodwell, RS Garfein Clinical Infectious Diseases 48 (1), 72-82, 2009 | 325 | 2009 |
Smartphone-enabled video-observed versus directly observed treatment for tuberculosis: a multicentre, analyst-blinded, randomised, controlled superiority trial A Story, RW Aldridge, CM Smith, E Garber, J Hall, G Ferenando, L Possas, ... The Lancet 393 (10177), 1216-1224, 2019 | 255 | 2019 |
Incarceration history and risk of HIV and hepatitis C virus acquisition among people who inject drugs: a systematic review and meta-analysis J Stone, H Fraser, AG Lim, JG Walker, Z Ward, L MacGregor, A Trickey, ... The Lancet Infectious Diseases 18 (12), 1397-1409, 2018 | 237 | 2018 |
Prevalence of hepatitis C virus infection among injection drug users in the United States, 1994–2004 JJ Amon, RS Garfein, L Ahdieh-Grant, GL Armstrong, LJ Ouellet, ... Clinical Infectious Diseases 46 (12), 1852-1858, 2008 | 230 | 2008 |
Correlates of HIV infection among young adult short-term injection drug users MC Doherty, RS Garfein, E Monterroso, D Brown, D Vlahov Aids 14 (6), 717-726, 2000 | 219 | 2000 |
A peer-education intervention to reduce injection risk behaviors for HIV and hepatitis C virus infection in young injection drug users RS Garfein, ET Golub, AE Greenberg, H Hagan, DL Hanson, SM Hudson, ... Aids 21 (14), 1923-1932, 2007 | 208 | 2007 |
Developing an HIV behavioral surveillance system for injecting drug users: the National HIV Behavioral Surveillance System A Lansky, AS Abdul-Quader, M Cribbin, T Hall, TJ Finlayson, RS Garfein, ... Public Health Reports 122 (1_suppl), 48-55, 2007 | 199 | 2007 |
Childhood sexual abuse and age at initiation of injection drug use DC Ompad, RM Ikeda, N Shah, CM Fuller, S Bailey, E Morse, P Kerndt, ... American journal of public health 95 (4), 703-709, 2005 | 197 | 2005 |
Variability in the incidence of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus infection among young injecting drug users in New York City DC Des Jarlais, T Diaz, T Perlis, D Vlahov, C Maslow, M Latka, ... American journal of epidemiology 157 (5), 467-471, 2003 | 194 | 2003 |
Problematic use of prescription-type opioids prior to heroin use among young heroin injectors RA Pollini, CJ Banta-Green, J Cuevas-Mota, M Metzner, E Teshale, ... Substance abuse and rehabilitation, 173-180, 2011 | 193 | 2011 |
The impact of digital health technologies on tuberculosis treatment: a systematic review BK Ngwatu, NP Nsengiyumva, O Oxlade, B Mappin-Kasirer, NL Nguyen, ... European Respiratory Journal 51 (1), 2018 | 187 | 2018 |
Self-reported hepatitis C virus antibody status and risk behavior in young injectors H Hagan, J Campbell, H Thiede, S Strathdee, L Ouellet, F Kapadia, ... Public health reports 121 (6), 710-719, 2006 | 184 | 2006 |